Most of you coming to this
Web Site know that I have
been diagnosed with Cancer,
and by now,  you know that
my Faith is my Light.   Goto
"
The Good News" page to
read  testimonies to God's
mercy and power.
Mark Birch
Counter
Procedure Date: 02/08/2010

Scope(s) Used Detail: GIF-HI 80-2806447

Introduction: A 54 year old male patient presents for Upper Endoscopic [ULTRASOUND].

Indications: Mr. Birch is a 54 year old male with a history of pancreatic cancer with
metastasis who presents for
evaluation of a nodule seen near the pancreatic head seen on recent surveilance PET scan.

Consent: The procedure, indications, potential complications (bleeding, perforation,
infection, adverse medication reaction), and alternatives to the procedure were discussed
with opportunity for questions. Informed consent was obtained.

Preparation: EKG, pulse, pulse oximetry, and blood pressure were monitored throughout the
procedure.

Medications: TIVA

Procedure: The endoscope was passed with ease through the mouth under direct
visualization to the duodenum The scope was withdrawn and the mucosa was carefully
examined. The views were good. The patient's toleration of the procedure was good.

Findings:
EGD Exam: The upper endoscope was introduced into the esopahgus. The proximal and
mid esophagus was normal in appearance. At the GEJ, mild erythema was noted consistent
with mild esophagitis. The GEJ was noted at 45cms. The stomach was carefully examined
including retroflexed views of the angularis, cardia, and fundus. No abnormalities were
noted. The first and the second portion of the duodenum appeared normal with no mucosal
abnormality.
EUS Exam: Olympus linear echoendoscope was used for this procedure. The pancreas was
carefully examined from the uncinate process to the tail where the spleen was seen. The
pancreatic duct was not dilated. The pancreatic parenchyma was normal in the pancreas
away from the biliary stent with no calcifications or lobulations. There was no evidence of a
mass or enlarged lymph node in the pancreas or adjacent to the pancreas. No
peri-pancreatic, peri-portal, celiac, or gastriclymph nodes were found.  Hypoechoic changes
were seen in the area of the stent consistent with inflammation. No distinct mass identified
around stent, in pancreas or in peri-pancreatic space.

Other Events: There were no complications.

Estimated Blood Loss: None.

Summary: 1) No lymph node/mass lesion seen in the pancreas or adjacent to the pancreas.
Suspect nodule seen on imaging is the same echogenicity as pancreatic parenchyma and
thus not visualized 2) Mild esophagitis

Recommendations:
1) Consider CT guided biopsy
2) PPI
3) Follow up with referring physician